clinical trial · NCT00144248
A Pharmacokinetic Study to Assess Nevirapine [Viramune] Levels in HIV Infected Patients With Impaired Hepatic Functions
Boehringer Ingelheim·phase4·completed·n = 51
HIV InfectionsHepatic Insufficiencynevirapine
brief summary
The objective of this study was to evaluate the steady-state clearance of nevirapine among HIV-1 positive patients with hepatic fibrosis, and to examine whether the degree of hepatic impairment influences clearance.
started
Jun 25, 2004
primary completion
Jun 1, 2006
completion
—
last updated
Dec 1, 2023
official title
A Pharmacokinetic Study to Assess Nevirapine Levels in HIV-infected Patients With Impaired Hepatic Function
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol